A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.

Madi, Lea; Bar-Yehuda, Sara; Barer, Faina; Ardon, Eti; Ochaion, Avivit; Fishman, Pnina

Madi, Lea; Bar-Yehuda, Sara; Barer, Faina; Ardon, Eti; Ochaion, Avivit; Fishman, Pnina.

Affiliation

Madi L; Can-Fite BioPharma Ltd., Kiryat-Matalon, Petach-Tikva 49170, Israel.

J Biol Chem ; 278(43): 42121-30, 2003 Oct 24.

Article in En | MEDLINE | ID: mdl-12865431

Subject(s)

Adenosine/analogs & derivatives; Melanoma/pathology; Neoplasm Proteins/metabolism; Receptor, Adenosine A3/metabolism; Adenosine/pharmacology; Animals; Cell Division; Cell Line, Tumor; Cyclin D1/biosynthesis; Down-Regulation; Melanoma/metabolism; Mice; Mice, Inbred C57BL; Neoplasm Proteins/biosynthesis; Neoplasm Proteins/drug effects; Neoplasms, Experimental/drug therapy; Protein Transport; Proto-Oncogene Proteins c-myc/biosynthesis; Receptor, Adenosine A3/biosynthesis; Receptor, Adenosine A3/drug effects; Signal Transduction

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adenosine / Receptor, Adenosine A3 / Melanoma / Neoplasm Proteins Type of study: Risk_factors_studies Limits: Animals Language: En Journal: J Biol Chem Year: 2003 Document type: Article Affiliation country: Israel Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links